Stock listing
VRCI Stock Price, News, Filings & Events — Verici Dx Plc
Selected listing: VRCI · LSE · GBX · GB
This page tracks Verici Dx Plc's VRCI:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VRCI:LSE. VRCI:LSE is the stock-level entry point for investors researching Verici Dx Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verici Dx Plc is a public company listed on the UK market under the ticker VRCI, with a market capitalization of approximately £10.73 million. The company focuses on developing innovative diagnostic solutions for organ transplant patients. Verici Dx aims to improve patient outcomes through its advanced technology and research initiatives.
- Ticker
- VRCI:LSE
- Asset type
- Stock
- Market cap
- $7.0M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- LSE
- Currency
- GBX
Verici Dx Plc VRCI:LSE stock context
This page tracks Verici Dx Plc's VRCI:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VRCI:LSE. VRCI:LSE is the stock-level entry point for investors researching Verici Dx Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verici Dx Plc is a public company listed on the UK market under the ticker VRCI, with a market capitalization of approximately £10.73 million. The company focuses on developing innovative diagnostic solutions for organ transplant patients. Verici Dx aims to improve patient outcomes through its advanced technology and research initiatives.
Latest news from Verici Dx Plc
Verici Dx Plc earnings calls
VERICI DX PLC (VRCI) — Investor Presentation
July 8, 2026 · Replay with transcript and chapters
VERICI DX PLC (VRCI) — Interim Results
October 7, 2025 · Replay with transcript and chapters
VERICI DX PLC (VRCI) — Business Update
July 16, 2024 · Replay with transcript and chapters
Verici Dx plc (VRCI) Q2 2024 Earnings Call
July 15, 2024 · Replay with transcript and chapters
VERICI DX PLC (VRCI) — Investor Presentation
November 22, 2023 · Replay with transcript and chapters
VERICI DX PLC (VRCI) — Investor Presentation
July 11, 2023 · Replay with transcript and chapters
Research Verici Dx Plc
Verici Dx Plc investor report
Review AI stock analysis and investor report context for VRCI:LSE.
Verici Dx Plc company profile
View the public company page for Verici Dx Plc on 6ix.
Verici Dx Plc news
Read company news and market updates connected to Verici Dx Plc.
Verici Dx Plc investor events
Find investor webinars, events, and replay context for Verici Dx Plc.
Alternate listings
A2QGXF:LSX
DE · EUR
Alternate listing for Verici Dx Plc; the primary context on this page is VRCI:LSE.
VRCDF:OTC
US · USD
Alternate listing for Verici Dx Plc; the primary context on this page is VRCI:LSE.
63V:FWB
DE · EUR
Alternate listing for Verici Dx Plc; the primary context on this page is VRCI:LSE.
A2QGXF:LS
DE · EUR
Alternate listing for Verici Dx Plc; the primary context on this page is VRCI:LSE.
63V:SWB
DE · EUR
Alternate listing for Verici Dx Plc; the primary context on this page is VRCI:LSE.